v3.8.0.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Series A Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Preferred Stock
Preferred stock, shares outstanding, beginning balance at Dec. 27, 2014             0
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs $ 0            
Preferred stock, shares outstanding, ending balance at Dec. 26, 2015             0
Beginning balance at Dec. 27, 2014 118,050 $ 32 $ 277,583 $ (159,859) $ 294   $ 0
Common stock, shares outstanding, beginning balance at Dec. 27, 2014   31,615          
Increase (Decrease) in Stockholders' Equity              
Exercises of stock options, shares   256          
Exercises of stock options 575   575        
Issuance of restricted stock units, shares   214          
Stock-based compensation 5,511   5,511        
Foreign currency translation adjustments (889)       (889)    
Issuance of common stock in connection with acquisitions, shares   191          
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs           $ 0  
Net income (loss) (34,995)     (34,995)      
Common stock, shares outstanding, ending balance at Dec. 26, 2015   32,276          
Ending balance at Dec. 26, 2015 88,252 $ 32 283,669 (194,854) (595)   $ 0
Increase (Decrease) in Temporary Equity [Roll Forward]              
Issuance of Series A Redeemable Convertible Preferred Stock, net of issuance costs of $2,124, shares             46
Issuance of Series A Redeemable Convertible Preferred Stock, net of issuance costs of $2,124             $ 44,226
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs $ (2,124)         2,124  
Preferred stock, shares outstanding, ending balance at Dec. 31, 2016 0           46
Increase (Decrease) in Stockholders' Equity              
Exercises of stock options, shares   373          
Exercises of stock options $ 1,406   1,406        
Issuance of restricted stock units, shares   513          
Stock-based compensation 6,504   6,504        
Return of stock related to settlement of Citrus Lane (Note 3), shares   (478)          
Return of stock related to settlement of Citrus Lane (Note 3) (2,593)   (2,593)        
Foreign currency translation adjustments 292       292    
Common stock repurchase, shares [1]   (3,700)          
Common stock repurchase [1] (30,524) $ (3) (30,521)        
Temporary Equity, Accretion of Interest           1,310  
Accretion of Series A Redeemable Convertible Preferred Stock dividends (1,310)   (1,310)        
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs (2,124)   (2,124)     (2,124)  
Net income (loss) $ 7,046     7,046      
Common stock, shares outstanding, ending balance at Dec. 31, 2016 28,984 28,984          
Ending balance at Dec. 31, 2016 $ 66,949 $ 29 255,031 (187,808) (303)   $ 47,660
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock dividends           2,599  
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs $ 0            
Preferred stock, shares outstanding, ending balance at Dec. 30, 2017 0           46
Increase (Decrease) in Stockholders' Equity              
Exercises of stock options, shares   840          
Exercises of stock options $ 3,907   3,906        
Issuance of restricted stock units, shares   566          
Issuance of restricted stock units (1)   (1)        
Stock-based compensation 9,693   9,693        
Foreign currency translation adjustments 849       849    
Accretion of Series A Redeemable Convertible Preferred Stock dividends (2,599)   (2,599)        
Accretion of Series A Redeemable Convertible Preferred Stock issuance costs           $ 0  
Net income (loss) $ 10,663     10,663      
Common stock, shares outstanding, ending balance at Dec. 30, 2017 30,390 30,390          
Ending balance at Dec. 30, 2017 $ 89,461 $ 30 $ 266,030 $ (177,145) $ 546   $ 50,259
[1] (1) Common stock repurchased was subsequently retired in fiscal 2016.